NCT03685370

Brief Summary

The use of epidural catheters for postoperative analgesia in pancreatic surgery is recommended by the guidelines of the ERAS society. Some studies claim it may expose to hemodynamic alterations that may compromise outcome and increase postoperative complications, attributable to a malfunction of the catheter itself, often linked to a bad positioning, since this is usually positioned with LOS technique. Our hypothesis is that a positioning made using the radiographic guide the day before the intervention can significantly reduce the number of catheter's dysfunctions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
154

participants targeted

Target at P75+ for not_applicable postoperative-pain

Timeline
Completed

Started Mar 2017

Longer than P75 for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2017

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

June 27, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 26, 2018

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
Last Updated

September 26, 2018

Status Verified

September 1, 2018

Enrollment Period

1.6 years

First QC Date

June 27, 2018

Last Update Submit

September 25, 2018

Conditions

Keywords

Epidural catheterpostoperative painLOS

Outcome Measures

Primary Outcomes (1)

  • Incidence of catheters malfunctions in LOS and X-ray group

    malfunctional catheters are defined as following: * symptomatic hypotension due to epidural infusion * NRS \> 6 in the first postoperative day and NRS \> 4 in subsequent postoperative day * overt malpositioning: * rx evidence of catheter's tip under T10 during routine rx or TC * NRS \> 6 (due to pain at T7-10 dermatomers) with 5 cc/h catheter infusion and response to lidocaine 1% 6ml bolus (low tip) * NRS \> 6 (due to pain at T7-10 dermatomers) with 5 cc/h catheter infusion and NO response to lidocaine 1% 6ml bolus ( not in epidural space or very low tip) * evidence of catheter accidental removal Numerical Rating Scale (NRS) is used to assess pain. Patients self-report actual pain on 0 to 10 scale where 0 is no pain and 10 is the worst immaginable pain.

    every day until 7th postoperative day

Secondary Outcomes (2)

  • Evaluate daily pain differences between groups: NRS (Numeric rating scale)

    every day until 7th postoperative day

  • Monitoring postoperative surgical complications between groups

    at 30th postoperative day

Study Arms (2)

LOS group

ACTIVE COMPARATOR

Patients randomized to recieve epidural catheter placement with LOS technique, without any Rx control

Procedure: LOS

X-ray group

EXPERIMENTAL

Patients randomized for X-ray placement of epidural catheter

Procedure: X-ray placement

Interventions

LOSPROCEDURE

placement of epidural catheters with LOS technique

LOS group

placement of epidural catheters with x-ray guide

X-ray group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • scheduled for open pancreatic surgery
  • ASA \< = 3

You may not qualify if:

  • scoliosis
  • coagulation abnormalities
  • antiplatelet drugs (except ASA)
  • history of back surgery
  • anticipated need of ICU stay

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienda ospedaliero-universitaria integrata Verona

Verona, Veneto, 37126, Italy

RECRUITING

MeSH Terms

Conditions

Pain, PostoperativePostoperative ComplicationsPancreatic Neoplasms

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Study Officials

  • Alvise Martini, MD

    AOUI Verona

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alvise Martini, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Principal Investigator

Study Record Dates

First Submitted

June 27, 2018

First Posted

September 26, 2018

Study Start

March 1, 2017

Primary Completion

September 30, 2018

Study Completion

September 30, 2019

Last Updated

September 26, 2018

Record last verified: 2018-09

Locations